#https://onecms-res.cloudinary.com/image/upload/s--tZe7nF85--/f_auto,q_auto/c_fill,g_auto,h_676,w_1200/v1/mediacorp/cna/image/2024/05/20/1716216134-image.jpg?itok=09CL7sn4

INFO:
Singapore will soon be able to fully produce personalised cancer treatment locally. Pharmaceutical giant AstraZeneca intends to build a S$2-billion facility to manufacture innovative medicine used in cancer treatments. Construction will start by end-2024 and it should be operational by 2029. This marks the first manufa
AstraZeneca to build $2b cancer drug manufacturing plant in Singapore